Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
James Hussey
AddedMar 31, 2024
UpdatedMay 31, 2026
James Hussey

James Hussey

CEO, Seneca Therapeutics

LinkedIn

James Hussey's Career

Seneca Therapeutics
Seneca Therapeutics

Blue Bell, PA, US

CEO· C-Suite · Management
Vodori
Vodori

Chicago, IL, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

James Hussey's Career

Seneca Therapeutics
Seneca Therapeutics
Series A$7.7M72018Blue Bell, PA, US
CEO· C-Suite · Management

Leadership at Seneca Therapeutics

Paul HallenbeckPaul HallenbeckFounder

Similar to Seneca Therapeutics

PineTree TherapeuticsPineTree TherapeuticsCambridge, MA, USBiotech Therapiesest. 2019PineTree TherapeuticsCambridge, MA, US · est. 2019

PineTree Therapeutics: Innovating biotech therapies in Oncology and Immuno-oncology.

Series B · $23.5M17
Palm TherapeuticsPalm TherapeuticsSan Diego, CA, USCancer Treatmentest. 2018Palm TherapeuticsSan Diego, CA, US · est. 2018

Revolutionizing cancer treatment with next-gen root-level therapeutics.

Angel · $991.1k7
Mana TherapeuticsMana TherapeuticsArlington, VA, USCancer Treatmentest. 2018Mana TherapeuticsArlington, VA, US · est. 2018

Passionate team harnessing immune cells to combat and confer lifelong immunity to cancer.

Series A · $49.5M7
Checkpoint TherapeuticsCheckpoint TherapeuticsWaltham, MA, USCancer Therapiesest. 2014Checkpoint TherapeuticsWaltham, MA, US · est. 2014

Checkpoint Therapeutics: A clinical-stage biopharmaceutical company focused on cancer therapy development.

Public · $10M24
Vodori
Vodori
Series A$11M562005Chicago, IL, US
Board Member· Board

Leadership at Vodori

Grant GochnauerGrant GochnauerCo-Founder
Richard W. GochnauerRichard W. GochnauerBoard Member
Feyzi FatehiFeyzi FatehiBoard Member
Scott RovegnoScott RovegnoBoard Member
Stacy WoltersStacy WoltersCo-Founder
Richard A Gadbois IIIRichard A Gadbois IIIBoard Member

Similar to Vodori

VodiumVodiumWashington, D.C., DC, USWebcastingest. 2020VodiumWashington, D.C., DC, US · est. 2020

Vodium, a DC-based company, offers innovative webcasting technology and services, integrating multimedia content.

Angel · $1.1M30
Veeva SystemsVeeva SystemsPleasanton, CA, USCloud Softwareest. 2007Veeva SystemsPleasanton, CA, US · est. 2007

Veeva Systems: Global cloud software solutions provider

Public6.7k
VohtrVohtrStaunton, VA, USAnalytics, Dataest. 2014VohtrStaunton, VA, US · est. 2014

Vohtr: Real-time opinion data provider for informed decision-making via tablets and mobile apps.

Seed · $905k1
VicomiVicomiSan Francisco, CA, USAnalytics, Platformest. 2013VicomiSan Francisco, CA, US · est. 2013

An IT service provider offering a visual platform that uses emotion-based tech to enhance user engagement and monetization.

Seed · $2.3M30

James Hussey's Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWillix HalimWillix HalimCEO · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · Kakao

People Similar to James Hussey

Tim SweeneyTim SweeneyCo-Founder · PracticingExcellenceJan SiegmundJan SiegmundBoard Member · WesternunionJay RobertsJay RobertsBoard Member · Vyant BioJohn RyuJohn RyuCo-Founder · HypothesisJonathan HalkyardJonathan HalkyardBoard Member · Shift4Dominic CarusoDominic CarusoBoard Member · Cystic Fibrosis Foundation